obesity |
18 |
humans |
14 |
inflammation |
14 |
adipose tissue |
13 |
animals |
12 |
insulin resistance |
12 |
mice |
12 |
female |
10 |
mice, inbred c57bl |
10 |
male |
9 |
metabolism |
9 |
sirt1 |
9 |
adipocytes - metabolism |
8 |
adipokine |
8 |
amino acid sequence |
8 |
animal experiment |
8 |
atherosclerosis |
8 |
biomarker |
8 |
breast cancer |
8 |
lipocalin-2 |
8 |
mitochondrial dysfunction |
8 |
proto-oncogene proteins c-akt - metabolism |
8 |
signal transduction - drug effects |
8 |
adiponectin |
7 |
adult |
7 |
aged |
7 |
cell membrane - metabolism |
7 |
diabetic cardiomyopathy |
7 |
electrophoresis, gel, two-dimensional |
7 |
endothelial dysfunction |
7 |
fatty acid-binding proteins - blood |
7 |
gluconeogenesis |
7 |
gut microbiota |
7 |
hepatocytes - metabolism |
7 |
insulin |
7 |
macrophages |
7 |
middle aged |
7 |
models, biological |
7 |
molecular sequence data |
7 |
risk factors |
7 |
signal transduction |
7 |
adaptor protein |
6 |
adaptor proteins, signal transducing - genetics - metabolism |
6 |
adipocyte |
6 |
adipose tissue - chemistry |
6 |
adiposity - physiology |
6 |
biogenesis |
6 |
blood glucose - analysis |
6 |
body mass index |
6 |
cell density |
6 |
cell line |
6 |
cell proliferation - drug effects |
6 |
chemicals and cas registry numbers |
6 |
cross-sectional studies |
6 |
endothelium |
6 |
enzyme activation - drug effects |
6 |
escherichia coli - genetics |
6 |
exercise |
6 |
follow-up studies |
6 |
gene expression |
6 |
glycosylation |
6 |
heart |
6 |
homeostasis |
6 |
hong kong - epidemiology |
6 |
hypertension - epidemiology |
6 |
hypertriglyceridemia - epidemiology |
6 |
likelihood functions |
6 |
lipids |
6 |
lipocalin |
6 |
medical sciences |
6 |
metabolic syndrome x - blood - epidemiology - etiology |
6 |
metalloporphyrins - pharmacology |
6 |
mice, obese |
6 |
obesity - epidemiology |
6 |
odds ratio |
6 |
ph domain and leucine zipper containing 1 (appl1) |
6 |
pharmacy and pharmacology environmental studies |
6 |
phosphotyrosine interaction |
6 |
polymerase chain reaction |
6 |
prospective studies |
6 |
proteins - metabolism |
6 |
proteome |
6 |
proteomics - methods |
6 |
rats |
6 |
tnf receptor-associated factor 6 - genetics - metabolism |
6 |
toxicology and environmental safety |
6 |
ubiquitination |
6 |
acyl coenzyme a - metabolism |
5 |
adaptor proteins, signal transducing - antagonists and inhibitors - genetics - physiology |
5 |
adaptor proteins, signal transducing - metabolism |
5 |
adipokines |
5 |
adiponectin - biosynthesis - metabolism |
5 |
adiponectin and adipokine |
5 |
affinity chromatography |
5 |
aging |
5 |
aging - metabolism |
5 |
anoxia - metabolism |
5 |
antineoplastic activity |
5 |
antineoplastic agents - pharmacology |
5 |
aorta, thoracic - drug effects - metabolism - physiopathology |
5 |
binding, competitive |
5 |
bioaccumulation |
5 |
biofilm |
5 |
biofilms |
5 |
biological markers - blood |
5 |
biotin |
5 |
cardio-renal metabolic syndrome |
5 |
cardiovascular disease |
5 |
carotid artery diseases - diagnosis |
5 |
carotid intima-media thickness |
5 |
carrier proteins - metabolism |
5 |
cell cycle proteins - metabolism |
5 |
cell movement - drug effects |
5 |
cells, cultured |
5 |
cyp2c9 |
5 |
diabetes |
5 |
diabetes mellitus, type 2 - enzymology |
5 |
drug resistance, fungal |
5 |
endothelin-1 - metabolism |
5 |
endothelium, vascular - drug effects - metabolism - physiopathology |
5 |
endothelium, vascular - drug effects - physiopathology |
5 |
energy metabolism |
5 |
enos |
5 |
exercise responsiveness |
5 |
fatty acid-binding proteins - physiology |
5 |
fatty-acid-binding proteins |
5 |
fgf21 |
5 |
gene knockdown techniques |
5 |
glucose - biosynthesis - metabolism |
5 |
glucose dysregulation |
5 |
gold compounds - pharmacology |
5 |
hepatocytes - enzymology |
5 |
humdisease |
5 |
hyperglycemia - diagnosis |
5 |
hypoxia |
5 |
inflammation - immunology - metabolism |
5 |
insulin - metabolism |
5 |
insulin - pharmacology |
5 |
interaction profiling |
5 |
ionization time of flight mass spectrometry |
5 |
jnk mitogen-activated protein kinases - genetics - metabolism |
5 |
lipocalins - genetics - physiology |
5 |
liquid chromatography-tan-dem mass spectrometry |
5 |
liver - drug effects - injuries - metabolism |
5 |
liver glycogen - metabolism |
5 |
liver injury |
5 |
longevity regulator |
5 |
macrophages - metabolism |
5 |
mammary neoplasms, experimental - drug therapy |
5 |
matrix-assisted laser desorption |
5 |
metabolic syndrome |
5 |
metabolic syndrome x - blood |
5 |
mice, nude |
5 |
microbiology |
5 |
mitochondria |
5 |
mitochondrial proteins - genetics - metabolism |
5 |
nerve tissue proteins - metabolism |
5 |
nitric oxide - metabolism |
5 |
obesity - blood |
5 |
obesity - blood - diagnosis |
5 |
obesity - metabolism - physiopathology |
5 |
obesity - physiopathology |
5 |
oncogene proteins - blood |
5 |
oncogene proteins - deficiency - genetics - physiology |
5 |
oxidative stress |
5 |
personalized medicine |
5 |
phosphorylation - drug effects |
5 |
plasminogen activator inhibitor 1 - biosynthesis |
5 |
polyamination |
5 |
porphyrin derivative |
5 |
protein binding |
5 |
protein interaction mapping - methods |
5 |
protein structure, tertiary |
5 |
proto-oncogene proteins - blood |
5 |
reactive oxygen species - metabolism |
5 |
recombinant proteins - genetics - metabolism |
5 |
rna interference |
5 |
rosiglitazone |
5 |
signaling |
5 |
sirt3 |
5 |
sirtuin 1 |
5 |
sirtuin 3 |
5 |
sirtuins - genetics - metabolism |
5 |
thiazolidinediones - toxicity |
5 |
time factors |
5 |
transcription factor ap-1 - genetics - metabolism |
5 |
transcription factor yy1 |
5 |
uncoupling protein 2 |
5 |
2-d dige |
4 |
2-de |
4 |
28 inflammation in type 2 diabetes |
4 |
3t3 cells |
4 |
3t3-l1 cells |
4 |
active transport, cell nucleus - drug effects |
4 |
adaptive thermogenesis |
4 |
adaptor proteins, signal transducing |
4 |
adipocyte precursor cells |
4 |
adipogenesis |
4 |
adipokines - blood |
4 |
adipokines - metabolism - pharmacology |
4 |
adiponectin - chemistry |
4 |
adiponectin - genetics - pharmacology |
4 |
adiponectin - pharmacology |
4 |
adipopharmacology |
4 |
adipose remodeling |
4 |
adipose tissue, brown - metabolism |
4 |
amp-activated protein kinases |
4 |
angiogenesis |
4 |
angiopoietin-like proteins |
4 |
angiopoietins |
4 |
anti-oxidant activity |
4 |
antioxidants - physiology |
4 |
apolipoprotein |
4 |
apoptosis - drug effects |
4 |
apoptosis - drug effects - physiology |
4 |
asian continental ancestry group |
4 |
autophagy |
4 |
bacteria - drug effects |
4 |
base sequence |
4 |
beiging |
4 |
beta catenin - metabolism |
4 |
biofilms - drug effects - growth and development |
4 |
blood proteins - physiology |
4 |
blood vessels - drug effects - metabolism |
4 |
blood-brain barrier |
4 |
blotting, northern |
4 |
breast carcinogenesis |
4 |
breast neoplasms - metabolism - pathology - therapy |
4 |
cancer stem cells |
4 |
candida |
4 |
candida albicans - genetics - pathogenicity - ultrastructure |
4 |
candida glabrata |
4 |
candida glabrata - drug effects - genetics - metabolism - physiology |
4 |
cardiovascular diseases |
4 |
cardiovascular diseases - blood - epidemiology - etiology |
4 |
carrier proteins - blood |
4 |
carrier proteins - genetics |
4 |
cattle |
4 |
cell cycle - drug effects |
4 |
cell differentiation |
4 |
cell line, tumor |
4 |
cell nucleus - drug effects - metabolism |
4 |
china |
4 |
cholesterol |
4 |
chromatography, high pressure liquid |
4 |
cloning, molecular |
4 |
creb-h |
4 |
culture media - chemistry - pharmacology |
4 |
cyclin d1 - metabolism |
4 |
diabetes mellitus, experimental - complications - enzymology - physiopathology |
4 |
dietary fats - administration & dosage - pharmacology |
4 |
dna, complementary - genetics |
4 |
dnmt1 |
4 |
drug resistance, fungal - genetics |
4 |
drug resistance, multiple, bacterial |
4 |
dyslipidaemia |
4 |
endothelium, vascular - drug effects - enzymology - physiology |
4 |
endothelium, vascular - drug effects - pathology |
4 |
endotoxemia |
4 |
energy metabolism - drug effects |
4 |
eosinophils |
4 |
eotaxin |
4 |
ets-domain protein elk-1 - biosynthesis |
4 |
extracellular signal-regulated map kinases - antagonists & inhibitors - metabolism |
4 |
fatty liver |
4 |
feeding behavior - drug effects |
4 |
fetal blood |
4 |
fibroblast growth factor 2 - pharmacology |
4 |
fibroblast growth factors - metabolism |
4 |
fish oil |
4 |
fungi - drug effects - physiology |
4 |
gene expression profiling |
4 |
gene therapy - methods |
4 |
genetic vectors |
4 |
glucose intolerance - complications - physiopathology |
4 |
glucose intolerance - genetics - metabolism |
4 |
glucose transport proteins, facilitative - biosynthesis |
4 |
glycogen synthase kinase 3 - antagonists & inhibitors - metabolism |
4 |
glycoproteins - blood |
4 |
heart failure |
4 |
hemin |
4 |
high-fat diet |
4 |
host-microbial interactions |
4 |
hypertriglyceridemia |
4 |
hypoxia-inducible factor 1, alpha subunit - genetics - metabolism |
4 |
isoliquiritigenin |
4 |
isometric contraction - drug effects - physiology |
4 |
ldlr |
4 |
lipid metabolism - drug effects |
4 |
lipoprotein lipase |
4 |
lipoproteins |
4 |
liver - drug effects - metabolism - physiopathology |
4 |
lysine - chemistry |
4 |
mammary tumorigenesis |
4 |
map kinase |
4 |
map kinase kinase kinases - antagonists & inhibitors - metabolism |
4 |
mass spectrometry |
4 |
metabolic syndrome x - blood - etiology |
4 |
microarray |
4 |
mitochondria - drug effects - metabolism |
4 |
motor activity - drug effects |
4 |
mouse models |
4 |
multienzyme complexes - genetics - metabolism |
4 |
muscle, skeletal - drug effects - enzymology - physiopathology |
4 |
mutagenesis, site-directed |
4 |
neovascularization |
4 |
neovascularization, physiologic - physiology |
4 |
nephrology |
4 |
neuroinflammation |
4 |
nf-κb pathway |
4 |
nitric oxide - biosynthesis |
4 |
nitric oxide synthase type iii - drug effects - metabolism |
4 |
obesity - blood - complications |
4 |
obesity - genetics - metabolism |
4 |
periodontal disease |
4 |
pharmacy and pharmacology psychology |
4 |
phosphorylation |
4 |
polyunsaturated fatty acids |
4 |
porcine coronary artery angioplasty |
4 |
prevalence |
4 |
protein 14-3-3 |
4 |
protein kinase b |
4 |
protein processing, post-translational |
4 |
protein-serine-threonine kinases - genetics - metabolism |
4 |
raf kinases - antagonists & inhibitors - metabolism |
4 |
receptors, adiponectin |
4 |
receptors, cell surface - genetics |
4 |
recombinant fusion proteins - metabolism |
4 |
recombinant proteins - administration & dosage - pharmacology |
4 |
regeneration |
4 |
resistance |
4 |
serum response factor - metabolism |
4 |
stress response |
4 |
stress, physiological |
4 |
thiazolidinediones - pharmacology |
4 |
triglycerides - blood |
4 |
two-dimensional gel electrophoresis |
4 |
type 2 immunity |
4 |
umbilical veins |
4 |
up-regulation - drug effects |
4 |
vascular endothelial growth factor a - pharmacology |
4 |
vasodilation - drug effects - physiology |
4 |
wif1 demethylation |
4 |
wnt/β-catenin signaling |
4 |
xenograft model antitumor assays - methods |
4 |
6-phytase - chemistry - metabolism |
3 |
a-fabp inhibitor |
3 |
acetylation |
3 |
acid phosphatase - chemistry - isolation & purification - metabolism - secretion |
3 |
active transport, cell nucleus |
3 |
adipocytes - drug effects |
3 |
adipocytes - drug effects - physiology |
3 |
adipocytes - physiology |
3 |
adiponectin - chemistry - genetics - metabolism - secretion |
3 |
adiponectin - metabolism |
3 |
adiponectin - pharmacology - physiology |
3 |
adiponectin - physiology |
3 |
adipose tissue - metabolism |
3 |
ageing |
3 |
akt |
3 |
alcohol drinking - metabolism |
3 |
alpha 2 macroglobulin |
3 |
alpha-macroglobulins - physiology |
3 |
alu |
3 |
amino acid motifs - physiology |
3 |
amino acid substitution |
3 |
ampk |
3 |
angiopoietins - genetics - metabolism |
3 |
animal cell |
3 |
anti-inflammatory agents - chemical synthesis - chemistry - pharmacology |
3 |
anti-oxidant |
3 |
antioxidants - chemistry - pharmacology |
3 |
apoptosis |
3 |
appl1 |
3 |
appl2 |
3 |
aromatic substituted pyrazoles |
3 |
atherosclerosis - enzymology - pathology |
3 |
bilirubin |
3 |
biological monitoring |
3 |
biology |
3 |
blood glucose - metabolism |
3 |
blood pressure |
3 |
blood proteins - chemistry - metabolism |
3 |
blotting, western |
3 |
breast neoplasms - etiology - metabolism - pathology |
3 |
c-jun n-terminal kinase (jnk) |
3 |
calorie restriction |
3 |
cardiovascular diseases - epidemiology |
3 |
cardiovascular diseases - etiology |
3 |
carnitine o-palmitoyltransferase - antagonists and inhibitors - genetics - metabolism |
3 |
carnitine palmitoyltransferase 1a (cpt1a) |
3 |
catalysis |
3 |
celastrol |
3 |
cell aging - physiology |
3 |
cell fractionation |
3 |
cell nucleus - metabolism |
3 |
cell proliferation |
3 |
chromatography, affinity |
3 |
chromatography, liquid |
3 |
circadian rhythm |
3 |
conserved sequence |
3 |
cpg islands |
3 |
culture media - chemistry |
3 |
cyclin-dependent kinase 5 |
3 |
cyclin-dependent kinase 5 - antagonists and inhibitors - physiology |
3 |
cycloheximide |
3 |
cytokines |
3 |
diabetes mellitus, type 2 - epidemiology |
3 |
differentiation |
3 |
dimerization |
3 |
dna methylation |
3 |
dna primers |
3 |
drug design |
3 |
dyslipidemias - blood |
3 |
endothelial cells |
3 |
endothelial senescence |
3 |
endothelium, vascular - enzymology - metabolism - pathology |
3 |
endothelium-dependent hyperpolarization |
3 |
endothelium-derived contracting factor |
3 |
endotoxin shock |
3 |
enzyme inhibitors - metabolism |
3 |
epigenesis, genetic |
3 |
escherichia coli |
3 |
escherichia coli - metabolism |
3 |
ethanol |
3 |
expression and purification |
3 |
extracellular fluid - metabolism |
3 |
extracellular matrix proteins - genetics |
3 |
fatty acid |
3 |
fatty acid-binding proteins - antagonists and inhibitors |
3 |
fatty acids - blood |
3 |
fatty acids - metabolism |
3 |
fatty acids - toxicity |
3 |
fatty acids, nonesterified - metabolism |
3 |
fatty liver - drug therapy |
3 |
fatty liver - etiology - physiopathology - therapy |
3 |
fatty liver disease |
3 |
fibroblast growth factor 21 |
3 |
fibroblast growth factors - blood |
3 |
fibroblasts |
3 |
fusion protein |
3 |
gene coverage |
3 |
gene density |
3 |
gene expression regulation - physiology |
3 |
gene expression regulation, neoplastic |
3 |
glucose - metabolism |
3 |
glucose tolerance test |
3 |
glycogen synthase kinase 3 - physiology |
3 |
glycoproteins - chemistry - isolation & purification - metabolism - secretion |
3 |
growth hormone |
3 |
guanine nucleotide binding protein |
3 |
hdl-cholesterol |
3 |
heme oxygenase-1 |
3 |
hepatic steatosis |
3 |
high fat diet |
3 |
hmgb1 |
3 |
hormone |
3 |
hormones |
3 |
human c1q and tumor necrosis factor related protein 2 (hctrp2) |
3 |
human gingival fibroblasts |
3 |
human platelet-derived growth factor a |
3 |
infection and periodontal disease |
3 |
inflammation related diseases |
3 |
inflammatory cytokines |
3 |
inflammatory mediators |
3 |
inflammatory response |
3 |
insulin - blood |
3 |
insulin resistance - physiology |
3 |
insulin sensitivity |
3 |
intercellular signaling peptides and proteins |
3 |
intercellular signaling peptides and proteins - blood - chemistry - isolation & purification |
3 |
intercellular signaling peptides and proteins - genetics |
3 |
isoelectric focusing |
3 |
issue 148 |
3 |
kinetics |
3 |
lactate dehydrogenase |
3 |
linkage disequilibrium blocks |
3 |
lipid a heterogeneity |
3 |
lipid metabolism |
3 |
lipopolysaccharide |
3 |
lipoprotein lipase - antagonists & inhibitors - genetics - metabolism |
3 |
liver |
3 |
liver - metabolism |
3 |
lkb1 |
3 |
macrophage infiltration and polarization |
3 |
macrophage polarization |
3 |
magnetic resonance spectroscopy |
3 |
mammary neoplasms, animal - metabolism - pathology |
3 |
mass spectrometry - methods |
3 |
mcd diet |
3 |
mesenchymal stem cells - chemistry - physiology |
3 |
metabolic inflammation |
3 |
metabolic syndrome x - blood - diagnosis |
3 |
metabolic syndrome x - complications - prevention & control |
3 |
methionine - metabolism |
3 |
mice, knockout |
3 |
mitogen activated protein kinase |
3 |
mmps |
3 |
molecular structure |
3 |
molecular weight |
3 |
molybdenum - pharmacology |
3 |
mutation |
3 |
na+-k+-atpase |
3 |
nanomicelles |
3 |
nash |
3 |
neoplasms, hormone-dependent - metabolism |
3 |
nf-κb |
3 |
nicotiana tabacum |
3 |
nicotinamide |
3 |
nitric oxide |
3 |
nitric oxide bioavailability |
3 |
nlrp3 inflammasome |
3 |
obesity - complications |
3 |
obesity - complications - metabolism |
3 |
obesity, morbid - blood |
3 |
p. gingivalis lps |
3 |
p25 |
3 |
peptide mapping - methods |
3 |
phosphorus |
3 |
phylogeny |
3 |
phytase |
3 |
phytate |
3 |
pi3k |
3 |
pichia - genetics |
3 |
pichia pastoris |
3 |
plant roots - enzymology |
3 |
polyphenols |
3 |
porphyromonas gingivalis |
3 |
ppar gamma - agonists - metabolism |
3 |
ppar gamma - physiology |
3 |
pressure overload |
3 |
pro-inflammatory adipokine |
3 |
proinflammatory cytokines |
3 |
promoter regions, genetic |
3 |
protease inhibitors |
3 |
protein expression |
3 |
protein isoforms |
3 |
protein processing, post-translational - drug effects |
3 |
protein purification |
3 |
protein structure, tertiary - physiology |
3 |
proteins - genetics - isolation & purification - metabolism |
3 |
proteome - analysis |
3 |
proteomics |
3 |
purple acid phosphatase |
3 |
pyrazoles - chemical synthesis - chemistry - pharmacology |
3 |
randomized controlled trials as topic |
3 |
receptors, estrogen - metabolism |
3 |
recombinant fusion proteins - genetics - isolation & purification - metabolism |
3 |
recombinant protein |
3 |
recombinant proteins - chemistry |
3 |
recombination |
3 |
reverse transcriptase polymerase chain reaction |
3 |
rna, small interfering |
3 |
root exudates |
3 |
senescence |
3 |
sequence alignment |
3 |
sequence alignment - methods |
3 |
sirtuin 1 - genetics - metabolism |
3 |
smooth muscle cell |
3 |
soil |
3 |
solanaceae |
3 |
soluble guanylyl cyclase |
3 |
sp1 transcription factor - physiology |
3 |
stilbenes - chemistry - pharmacology |
3 |
substrate specificity |
3 |
systolic arterial blood pressure |
3 |
thrombospondin-1 |
3 |
tobacco |
3 |
tobacco - enzymology |
3 |
toll-like receptor (tlr)-4 |
3 |
triglycerides - metabolism |
3 |
trypsin - chemistry |
3 |
type 2 diabetes |
3 |
vascular smooth muscle |
3 |
vasodilatation |
3 |
wine - analysis |
3 |
acetaminophen |
2 |
acetyl-coa carboxylase - metabolism |
2 |
acute liver injury |
2 |
acute-phase proteins - metabolism - pharmacology |
2 |
adaptor proteins, signal transducing - physiology |
2 |
adductor muscle |
2 |
adenylyl cyclase |
2 |
adiponectin - chemistry - pharmacology |
2 |
adiponectin - metabolism - pharmacology |
2 |
akt2 |
2 |
amp-activated protein kinases - metabolism |
2 |
amylin |
2 |
amyloid - antagonists & inhibitors - pharmacology - physiology |
2 |
amyloid - pharmacology |
2 |
animal proteomics |
2 |
antioxidants - pharmacology |
2 |
aorta |
2 |
aorta - metabolism |
2 |
arterial stiffness |
2 |
biological sciences |
2 |
biological transport, active - drug effects |
2 |
biomarker discovery |
2 |
cadmium |
2 |
calcitonin gene-related peptide |
2 |
calcitonin gene-related peptide - pharmacology |
2 |
calcium overload |
2 |
cardiac fibrosis |
2 |
cardiac hypertrophy |
2 |
cardiometabolic disease |
2 |
cardiovascular surgery |
2 |
cell aging |
2 |
cell aging - drug effects - genetics |
2 |
cell biology |
2 |
cell nucleus - enzymology |
2 |
cell survival |
2 |
chemical fractionation - methods |
2 |
chromatography, deae-cellulose - methods |
2 |
chromatography, gel - methods |
2 |
cl316243 |
2 |
coronary artery bypass surgery |
2 |
coronary vessels - drug effects - metabolism |
2 |
cos cells |
2 |
dexamethasone - pharmacology |
2 |
dextrans |
2 |
diabetic complications |
2 |
diastolic heart failure |
2 |
diet, high-fat |
2 |
dietary fats - pharmacology |
2 |
digestive system - cytology |
2 |
disease models, animal |
2 |
dna, complementary - metabolism |
2 |
dose-response relationship, drug |
2 |
duodenum |
2 |
duodenum - cytology |
2 |
early vascular ageing |
2 |
electron transport chain |
2 |
electrophoresis, polyacrylamide gel |
2 |
electrophoretic mobility shift assay |
2 |
embryo, nonmammalian |
2 |
endothelial cells - drug effects - metabolism |
2 |
endothelium-dependent contractions |
2 |
enzyme activation |
2 |
enzyme inhibitors - pharmacology |
2 |
epinephrine |
2 |
epinephrine - pharmacology |
2 |
er stress |
2 |
exerkines |
2 |
feedback |
2 |
fibrosis |
2 |
forskolin - pharmacology |
2 |
free radical scavengers - pharmacology |
2 |
fsp27 |
2 |
gastroenterology |
2 |
gene expression - drug effects |
2 |
gene expression profiling - methods |
2 |
gene expression regulation |
2 |
glucose and fatty acid uptake and metabolism |
2 |
glucose transporter type 4 - metabolism |
2 |
heart failure with preserved ejection fraction |
2 |
heat-shock proteins |
2 |
heat-shock proteins - metabolism |
2 |
heme oxygenase 1 |
2 |
hepatopancreas |
2 |
high-density fermentation |
2 |
hindlimb - metabolism |
2 |
hsp20 heat-shock proteins |
2 |
human umbilical vein endothelial cells - metabolism |
2 |
hydrogen peroxide |
2 |
hydrogen-ion concentration |
2 |
hyperglycemia - genetics - metabolism |
2 |
hyperhomocysteinemia |
2 |
hyperinsulinism - genetics - metabolism |
2 |
hypertension |
2 |
immunohistochemistry |
2 |
insulin antagonists - pharmacology |
2 |
insulin-like growth factor i - pharmacology |
2 |
interleukin-6 |
2 |
interleukin-6 - biosynthesis - chemistry - immunology - isolation & purification |
2 |
ion channels - deficiency - genetics - metabolism |
2 |
islet amyloid polypeptide |
2 |
isoelectric point |
2 |
isoenzymes - antagonists & inhibitors - genetics - metabolism |
2 |
kidney injury |
2 |
left ventricular hypertrophy |
2 |
lipocalins - metabolism - pharmacology |
2 |
lipocalin‐2 |
2 |
low abundant protein |
2 |
lymphocytes - immunology |
2 |
membrane protein |
2 |
membrane proteins - biosynthesis - chemistry - physiology |
2 |
mesenteric arteries - drug effects - metabolism - physiopathology |
2 |
metabolic diseasec |
2 |
metabolic disorders |
2 |
metallothionein isoform |
2 |
methylnicotinamide |
2 |
mitochondrial biogenesis |
2 |
mitochondrial proteins - deficiency - genetics - metabolism |
2 |
models, animal |
2 |
models, genetic |
2 |
molecular physiology |
2 |
multienzyme complexes - metabolism |
2 |
muscle proteins - chemistry |
2 |
muscle proteins - genetics - isolation & purification - metabolism |
2 |
muscle proteins - metabolism |
2 |
muscle proteins - metabolism - physiology |
2 |
muscle, skeletal - drug effects - metabolism |
2 |
muscle, skeletal - metabolism |
2 |
muscle, smooth, vascular - metabolism |
2 |
mussel |
2 |
myoblasts, skeletal - drug effects - metabolism |
2 |
myocardium - metabolism |
2 |
myocytes, cardiac - cytology - metabolism |
2 |
myocytes, cardiac - metabolism |
2 |
myography |
2 |
neutrophil |
2 |
nf-kappa b - metabolism |
2 |
nfκb |
2 |
nitric oxide synthase - antagonists & inhibitors - metabolism |
2 |
obesity - etiology - metabolism - physiopathology |
2 |
oligonucleotide array sequence analysis |
2 |
oncogene proteins - metabolism - pharmacology |
2 |
organ culture techniques |
2 |
oxidation-reduction |
2 |
oxidative stress - drug effects - genetics |
2 |
p20 |
2 |
p53 |
2 |
palmitates - metabolism |
2 |
pancreas |
2 |
pancreas - cytology |
2 |
peptide mapping |
2 |
perna viridis |
2 |
phosphatidylinositol 3-kinases - metabolism |
2 |
phospholipase c beta |
2 |
phosphopeptides - chemistry |
2 |
phosphopeptides - isolation & purification |
2 |
phosphoprotein |
2 |
phosphoproteins - chemistry |
2 |
phosphoproteins - genetics - isolation & purification - metabolism |
2 |
phosphorylation ampk |
2 |
pichia - genetics - metabolism |
2 |
polyethylene glycols - metabolism |
2 |
precipitin tests |
2 |
precision medicine |
2 |
prostacyclin |
2 |
protein isoforms - metabolism |
2 |
protein kinase c - antagonists & inhibitors - metabolism |
2 |
protein kinase c-alpha |
2 |
protein-serine-threonine kinases - metabolism |
2 |
rats, wistar |
2 |
reactive oxygen species |
2 |
recombinant proteins - biosynthesis - chemistry - immunology - isolation & purification |
2 |
recombinant proteins - chemistry - pharmacology |
2 |
recombinant proteins - metabolism |
2 |
reference values |
2 |
regional blood flow |
2 |
rna, messenger - metabolism |
2 |
sample prefractionation |
2 |
seipin |
2 |
serine - metabolism |
2 |
silent information regulator |
2 |
sirtuin |
2 |
sirtuin 1 - metabolism |
2 |
spontaneously hypertensive rat |
2 |
stem cells - cytology |
2 |
stomach |
2 |
stomach - cytology |
2 |
stress |
2 |
sus scrofa |
2 |
tetrazolium salts - metabolism |
2 |
thiazoles - metabolism |
2 |
thromboxane-prostanoid receptor |
2 |
tissue distribution |
2 |
titin |
2 |
toll-like receptors |
2 |
traditional chinese medicine |
2 |
transfection |
2 |
tumor necrosis factor-alpha - metabolism |
2 |
tumor suppressor protein p53 - metabolism |
2 |
type c phospholipases - genetics - metabolism |
2 |
uncoupling protein |
2 |
vascular endothelial dysfunction |
2 |
vascular inflammation |
2 |
vasodilation - drug effects |
2 |
vasodilator agents - pharmacology |
2 |
wat remodeling |
2 |
xenopus |
2 |
xenopus laevis |
2 |
xenopus proteins - physiology |
2 |
zebrafish |
2 |
5-hydroxytryptamine receptor agonist |
1 |
acute-phase proteins - physiology |
1 |
adipocyte progenitor |
1 |
adiposity |
1 |
age |
1 |
anti-obesity agents - adverse effects - pharmacology |
1 |
anti-obesity drug |
1 |
arterial remodelling |
1 |
arteries |
1 |
atp-sensitive potassium channel opener |
1 |
benzazepines - adverse effects - pharmacology |
1 |
bone and bones - pathology - radiography |
1 |
bone ultrastructure |
1 |
breast milk |
1 |
cardiometbolic diseases |
1 |
cardiovascular diseases - etiology - prevention and control |
1 |
caspase inhibitor |
1 |
clinical trial |
1 |
collagen |
1 |
contractile function |
1 |
dietary restriction |
1 |
disulfide bond |
1 |
drug discovery |
1 |
elastin |
1 |
electron microscopy |
1 |
endothelial cell |
1 |
endothelium, vascular - drug effects - physiology |
1 |
fat depots |
1 |
femur - pathology - radiography |
1 |
fructose-fed rats |
1 |
full matrix algebras |
1 |
generalized matrix algebras |
1 |
ghrelin |
1 |
high-fat |
1 |
hypertension - physiopathology - prevention and control |
1 |
infant adiposity |
1 |
intermediary metabolites |
1 |
iptakalim |
1 |
katp channels - agonists |
1 |
knockout mouse |
1 |
lean men |
1 |
leptin |
1 |
leptin receptor |
1 |
lie derivations |
1 |
lifespan |
1 |
lipocalins - physiology |
1 |
lipotoxicity |
1 |
mct |
1 |
mechanical properties |
1 |
metabolic syndrome x - metabolism - therapy |
1 |
mice, mutant strains |
1 |
microcirculation |
1 |
nad |
1 |
obesity - complications - drug therapy |
1 |
obesity - metabolism - therapy |
1 |
oligomeric assembly |
1 |
phenotype |
1 |
postprandial |
1 |
pregnancy |
1 |
premature senescence |
1 |
primary endothelial cells |
1 |
propylamines - pharmacology |
1 |
protein acetylation |
1 |
protein–protein interaction |
1 |
proto-oncogene proteins - physiology |
1 |
receptors, leptin - deficiency - metabolism |
1 |
replicative senescence |
1 |
saturated fatty acids |
1 |
senolytics |
1 |
serotonin receptor agonists - adverse effects - pharmacology |
1 |
sirt-1 |
1 |
sirtuins |
1 |
small lipid-binding protein |
1 |
spontaneously hypertensive rats |
1 |
therapeutic targets |
1 |
triangular algebras |
1 |
w42a mutant |
1 |